Depending on strict quality assurance system, up-to-date facilities, and advanced process, Huapont Pharm. provides a reliable guarantee of product quality. Huapont Pharm.'s strategy is to pursue excellence and innovation at all levels, from manufacturing production units to quality systems and customer care.
Huapont Pharm. has been inspected and approved by US-FDA since 2012. Huapont Pharm. past the USFDA inspection without 483 tables in September 2015.
This is the confirmation that our cGMP system is state-of-the-art and compliant with the most recent guidelines and validates our strategy of having an excellent system in place serving our partners
Written Confirmation granted by China CFDA Huapont Pharm. is regularly inspected by China CFDA ( China Food and Drug Administration)
GMP certificate granted by New Zealand MEDSAFE (Medicines abd Medical Devices Safety Authority）
ASMF for Calcipotriol Anhydrous(Calcipotriene Anhydrous) was approved by Greek EOF (National Organization for Medicines)
Certificate for Naftifine HCl approved by Russian MOH
Certificate for Naftifine HCl approved by Ukraine
GMP certificate granted by China CFDA. Huapont Pharm. is regularly inspected by China CFDA ( China Food and Drug Administration)
Copyright © 2018 Chongqing Huapont Pharmaceutical Co., Ltd. All Rights Reserved.